93 related articles for article (PubMed ID: 23383595)
1. Invasive and prognostic significance of pRB in esophageal squamous cell carcinoma: a meta-analysis.
Wang MT; Zhang JJ; Xu LY; Cao J; Chen S; Ma CS; Fang ZM; Meng LY; Lan B; Li EM
Dis Esophagus; 2013; 26(7):723-8. PubMed ID: 23383595
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of retinoblastoma protein (pRB) expression in esophageal squamous cell carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
J Surg Oncol; 2000 Feb; 73(2):104-8. PubMed ID: 10694647
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma-protein (prb) expression and prognosis in squamous-cell carcinomas of the esophagus.
zur Hausen A; Sarbia M; Heep H; Willers R; Gabbert HE
Int J Cancer; 1999 Dec; 84(6):618-22. PubMed ID: 10567909
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma.
Wang MT; Chen G; An SJ; Chen ZH; Huang ZM; Xiao P; Ben XS; Xie Z; Chen SL; Luo DL; Tang JM; Lin JY; Zhang XC; Wu YL
Dis Esophagus; 2012; 25(7):664-70. PubMed ID: 22150974
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic role of cyclin D1 in esophageal squamous cell carcinoma: a meta-analysis.
Zhao J; Li L; Wei S; Gao Y; Chen Y; Wang G; Wu Z
Dis Esophagus; 2012 Aug; 25(6):520-6. PubMed ID: 22098104
[TBL] [Abstract][Full Text] [Related]
6. Stage II esophageal carcinoma: the significance of T and N.
Killinger WA; Rice TW; Adelstein DJ; Medendorp SV; Zuccaro G; Kirby TJ; Goldblum JR
J Thorac Cardiovasc Surg; 1996 May; 111(5):935-40. PubMed ID: 8622316
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Kaibara N
J Cancer Res Clin Oncol; 2001 Sep; 127(9):531-6. PubMed ID: 11570573
[TBL] [Abstract][Full Text] [Related]
8. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of the T2 substage in patients with esophageal squamous cell carcinoma.
Duan J; Deng T; Ying G; Zhang H; Zhou L; Bai M; Li H; Ba Y
Dis Esophagus; 2017 Apr; 30(4):1-7. PubMed ID: 28375473
[TBL] [Abstract][Full Text] [Related]
10. Association between positive murine double minute 2 expression and clinicopathological characteristics of esophageal squamous cell carcinoma: a meta-analysis.
Chen JY; Yang H; Wen J; Luo KJ; Liu QW; Lei JY; Zhen YZ; Fu JH
Dis Esophagus; 2016 Oct; 29(7):856-863. PubMed ID: 25873358
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of overexpressed p16(INK4A) in esophageal squamous cell carcinoma: a meta-analysis.
Wang L; Li J; Yu X; Zhang Z; Pang L; Li S; Hou J; Li F
Biomark Med; 2016 May; 10(5):537-46. PubMed ID: 27071776
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
14. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
15. No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis.
Ge XQ; Yang YZ; Li SS; Hou L; Ren JL; Yang KP; Fa XE
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):462-468. PubMed ID: 28585132
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.
Saeki H; Tsutsumi S; Tajiri H; Yukaya T; Tsutsumi R; Nishimura S; Nakaji Y; Kudou K; Akiyama S; Kasagi Y; Nakanishi R; Nakashima Y; Sugiyama M; Ohgaki K; Sonoda H; Oki E; Maehara Y
Ann Surg; 2017 Mar; 265(3):527-533. PubMed ID: 28169928
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
Wang H; Deng F; Liu Q; Ma Y
Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
[TBL] [Abstract][Full Text] [Related]
19. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
[TBL] [Abstract][Full Text] [Related]
20. High expression of glucose transporter 1 on primary lesions of esophageal squamous cell carcinoma is associated with hematogenous recurrence.
Sawayama H; Ishimoto T; Watanabe M; Yoshida N; Baba Y; Sugihara H; Izumi D; Kurashige J; Baba H
Ann Surg Oncol; 2014 May; 21(5):1756-62. PubMed ID: 24242681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
